Overview
Mullerian inhibiting factor (MIF) deficiency, often associated with anomalies in Müllerian duct development, leads to conditions such as Herlyn-Werner-Wunderlich syndrome and Persistent Mullerian duct syndrome (PMDS). These conditions manifest as structural abnormalities in the reproductive tract due to impaired Müllerian duct regression.Diagnosis
Key Diagnostic Criteria: Uterus didelphys, obstructed hemivagina, ipsilateral renal agenesis (Herlyn-Werner-Werner-Wunderlich syndrome) 1.
Imaging Techniques: Prenatal ultrasound, MRI, and hysterosalpingography are crucial for detecting and classifying Müllerian duct anomalies 2.
Genetic Testing: Mutations in AMH or AMHR2 genes can be identified through genetic analysis, though normal serum AMH levels may still indicate functional defects 34.Management
Surgical Intervention: Early surgical correction for neonatal cases to prevent complications like hematocolpos 1.
Interventional Therapy: Guided by accurate imaging to manage structural anomalies effectively 2.
Monitoring Hormones: Serum AMH levels may be normal despite genetic mutations affecting function, necessitating clinical correlation 34.Special Populations
Pediatrics: Neonatal diagnosis and early surgical intervention are critical to prevent long-term complications 1.
Pregnancy: Not specifically addressed in the provided abstracts.
Comorbidities: Renal agenesis associated with Herlyn-Werner-Wunderlich syndrome requires multidisciplinary care 1.Key Recommendations
Consider Herlyn-Werner-Wunderlich syndrome in cases of prenatal renal agenesis and pelvic masses, facilitating timely neonatal intervention (Evidence: Moderate 1).
Utilize MRI for accurate diagnosis and characterization of Müllerian duct anomalies due to its high accuracy (Evidence: Strong 2).
Genetic testing for AMH and AMHR2 mutations is essential, even when serum AMH levels are normal, to understand functional impacts (Evidence: Moderate 34).References
1 Tuna T, Estevão-Costa J, Ramalho C, Fragoso AC. Herlyn-Werner-Wunderlich Syndrome: Report of a Prenatally Recognised Case and Review of the Literature. Urology 2019. link
2 Chandler TM, Machan LS, Cooperberg PL, Harris AC, Chang SD. Mullerian duct anomalies: from diagnosis to intervention. The British journal of radiology 2009. link
3 Menabò S, Balsamo A, Nicoletti A, Gennari M, Pirazzoli P, Cicognani A et al.. Three novel AMH gene mutations in a patient with persistent mullerian duct syndrome and normal AMH serum dosage. Hormone research 2008. link
4 Hoshiya M, Christian BP, Cromie WJ, Kim H, Zhan Y, MacLaughlin DT et al.. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene. Birth defects research. Part A, Clinical and molecular teratology 2003. link